Vol. 9 No. 1 (2022): Volume 9 Issue 1 (2022)
Volume 9, Number : 1
February 14, 2022
Current Issue
Volume 9 Issue 3 (2022)
Volume 9, Number : 3

A New Approch to Formulate and Optimizethe Porous Tablets Containing Loratidine

Jul 6, 2022
T. Balavikas, H.Parameshwar, A.V. Jithan
PDF
Statistic: 0

Method Development, Validation and Stability Studies of Carsoprodal in API and Pharmaceutical Dosage Form By RP-HPLC

Jul 6, 2022
M.Nandini, H.Parameshwar, A.V. Jithan
PDF
Statistic: 0

A Review on Wilms Tumor

Dr.S.Kameshwaran, J.Jeyashree, R.Kalimuthu, S.Karthikeyan
PDF
Statistic: 0

Current Issue

Vol. 9 No. 2 (2022): Vol. 9 No. 2 (2022): Volume 9 Issue 2 (2022)

Published: Jun 2, 2022

Articles

A review on adverse drug reaction reporting pattern

84-88 MohdWasiullah, MoidRaza, Nitesh Kumar, Piyushyadav

An overview on national scenario on pharmacovigilance and medication error

MohdWasiullah, TarunSahu, ShivamChaurasia, Manoj Kumar Yadav, Piyush yadav

Formulation and evaluation of praziquantel chewable tablet for helmenthiasis treatment

R. Suresh, S. Chandra, A. Sureshkumar, S. Kavibharathi, S. Sangeetha, P. Dhivya Bharathi

Development and characterization of anti-hiv drug (zudovudine) controlled release matrix tablets

89-94 M. Manasa, Sai Lakshmi, H. Parameshwar, A.V. Jithan

Method development and validation for the simultaneous estimation of darunavir hcland cobicistat in pure and combined tablet dosage form by RP-HPLC

95-103 Mohammed Shaibaz, H. Parameshwar, A.V. Jithan

Design, Prepare and Characterization of Calcium Channel Blocker (Diltiazem) Microspheres Using Natural Polymers

104-111 Ayesha Sultana, H. Parameshwar, A.V. Jithan, M. Sai Lakshmi

Formulation and evaluation of praziquantel chewable tablet for helmenthiasis treatment

112-118 R. Suresh, S. Chandra, S. Sangeetha, S. Kavibharathi, A. Sureshkumar, P. Dhivya Bharathi
View All Issues